CLX-NEU-161A11

N/A

Report date: 2023/01/01 20:19:17
NME

Base Information

Drug NameCLX-NEU-161A11
Drug Alias NameCLX-NEU-161A11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellix Bio Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCellix Bio Pvt Ltd
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A